Pharmacovigilance Market Analysis And Forecast To 2032: By Clinical Trial Phase (Preclinical, Phase I, Phase II, Phase III, and Phase IV), Service Provider (In-house and Contract Outsourcing), Type of Reporting (Spontaneous Reporting, Intensified ADR Reporting, Targeted Spontaneous Reporting, Cohort Event Monitoring, and EHR Mining), End User (Pharmaceuticals, Biotechnology Companies, Medical Device Manufacturers, Others), And By Region